Cargando…
More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease
Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005110/ https://www.ncbi.nlm.nih.gov/pubmed/21132354 http://dx.doi.org/10.1007/s10974-010-9231-8 |
_version_ | 1782194066974310400 |
---|---|
author | Hamdani, Nazha Borbély, Attila Veenstra, Sophie P. G. R. Kooij, Viola Vrydag, Wim Zaremba, Ruud dos Remedios, Cris Niessen, Hans W. M. Michel, Martin C. Paulus, Walter J. Stienen, Ger J. M. van der Velden, Jolanda |
author_facet | Hamdani, Nazha Borbély, Attila Veenstra, Sophie P. G. R. Kooij, Viola Vrydag, Wim Zaremba, Ruud dos Remedios, Cris Niessen, Hans W. M. Michel, Martin C. Paulus, Walter J. Stienen, Ger J. M. van der Velden, Jolanda |
author_sort | Hamdani, Nazha |
collection | PubMed |
description | Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study a comprehensive analysis was made of mediators of the βAR pathway, myofilament properties and cardiac structure in patients with idiopathic (IDCM; n = 13) and ischemic (ISHD; n = 10) cardiomyopathy in comparison to non-failing hearts (donor; n = 10) for the following parameters: βAR density, G-coupled receptor kinases 2 and 5, stimulatory and inhibitory G-proteins, phosphorylation of myofilament targets of PKA, protein phosphatase 1, phospholamban, SERCA2a and single myocyte contractility. All parameters exhibited the expected alterations of heart failure, but for most of them the extent of alteration was greater in IDCM than in ISHD. Histological analysis also revealed higher collagen in IDCM compared to ISHD. Alterations in the βAR pathway are more pronounced in IDCM than in ISHD and may reflect sequential changes in cellular protein composition and function. Our data indicate that cellular dysfunction is more severe in IDCM than in ISHD. |
format | Text |
id | pubmed-3005110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-30051102011-01-19 More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease Hamdani, Nazha Borbély, Attila Veenstra, Sophie P. G. R. Kooij, Viola Vrydag, Wim Zaremba, Ruud dos Remedios, Cris Niessen, Hans W. M. Michel, Martin C. Paulus, Walter J. Stienen, Ger J. M. van der Velden, Jolanda J Muscle Res Cell Motil Original Paper Activation of the β-adrenergic receptor (βAR) pathway is the main mechanism of the heart to increase cardiac output via protein kinase A (PKA)-mediated phosphorylation of cellular target proteins, and perturbations therein may contribute to cardiac dysfunction in heart failure. In the present study a comprehensive analysis was made of mediators of the βAR pathway, myofilament properties and cardiac structure in patients with idiopathic (IDCM; n = 13) and ischemic (ISHD; n = 10) cardiomyopathy in comparison to non-failing hearts (donor; n = 10) for the following parameters: βAR density, G-coupled receptor kinases 2 and 5, stimulatory and inhibitory G-proteins, phosphorylation of myofilament targets of PKA, protein phosphatase 1, phospholamban, SERCA2a and single myocyte contractility. All parameters exhibited the expected alterations of heart failure, but for most of them the extent of alteration was greater in IDCM than in ISHD. Histological analysis also revealed higher collagen in IDCM compared to ISHD. Alterations in the βAR pathway are more pronounced in IDCM than in ISHD and may reflect sequential changes in cellular protein composition and function. Our data indicate that cellular dysfunction is more severe in IDCM than in ISHD. Springer Netherlands 2010-12-04 2010 /pmc/articles/PMC3005110/ /pubmed/21132354 http://dx.doi.org/10.1007/s10974-010-9231-8 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Paper Hamdani, Nazha Borbély, Attila Veenstra, Sophie P. G. R. Kooij, Viola Vrydag, Wim Zaremba, Ruud dos Remedios, Cris Niessen, Hans W. M. Michel, Martin C. Paulus, Walter J. Stienen, Ger J. M. van der Velden, Jolanda More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title_full | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title_fullStr | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title_full_unstemmed | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title_short | More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
title_sort | more severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart disease |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005110/ https://www.ncbi.nlm.nih.gov/pubmed/21132354 http://dx.doi.org/10.1007/s10974-010-9231-8 |
work_keys_str_mv | AT hamdaninazha moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT borbelyattila moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT veenstrasophiepgr moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT kooijviola moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT vrydagwim moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT zarembaruud moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT dosremedioscris moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT niessenhanswm moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT michelmartinc moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT pauluswalterj moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT stienengerjm moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease AT vanderveldenjolanda moreseverecellularphenotypeinhumanidiopathicdilatedcardiomyopathycomparedtoischemicheartdisease |